Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

Akebia Therapeutics (AKBA) Long-Term Debt Issuances (2024 - 2025)

Akebia Therapeutics (AKBA) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $10.0 million as the latest value for Q1 2025.

  • On a quarterly basis, Long-Term Debt Issuances fell 72.97% to $10.0 million in Q1 2025 year-over-year; TTM through Dec 2025 was $10.0 million, a 77.78% decrease, with the full-year FY2025 number at $10.0 million, down 77.78% from a year prior.
  • Long-Term Debt Issuances was $10.0 million for Q1 2025 at Akebia Therapeutics, up from $8.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $37.0 million in Q1 2024 to a low of $8.0 million in Q2 2024.